These observations suggest that serum NSE levels could be elevated in patients with nonmalignant pulmonary diseases accompanied by active inflammation, whereas there is no comprehensive study assessing the significance of serum NSE as a biomarker for sarcoidosis. Here, ENO2 is linked to lung disorder.